Christos S. Katsanos

Dr. Christos S. Katsanos

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Nutrition Research
Verified
Journal Article
Closed access
Christos S. KatsanosChristos S. Katsanos
Christos S. Katsanos
DCDavid L. Chinkes
David L. Chinkes
DPDouglas Paddon-Jones
Douglas Paddon-Jones
XZXiao-Jun Zhang
Xiao-Jun Zhang
AAAsle Aarsland
Asle Aarsland
RWRobert R. Wolfe
Robert R. Wolfe

1 March 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Anaissa Ruiz TejadaAnaissa Ruiz Tejada
Anaissa Ruiz Tejada
JNJanet L. Neisewander
Janet L. Neisewander
Christos S. KatsanosChristos S. Katsanos
Christos S. Katsanos
Physical activity leads to well-established health benefits. Current efforts to enhance physical activity have targeted mainly socioeconomic factors. However, despite these efforts, only a small number of adults engage in regular physical activity to the point of meeting current recommendations. Evidence collected in rodent models and humans establish a strong central nervous system component that regulates physical activity behavior. In particular, dopaminergic pathways in the central nervous system are among the best-characterized biological mechanisms to date with respect to regulating reward, motivation, and habit formation, which are critical for establishing regular physical activity. Herein, we discuss evidence for a role of brain dopamine in the regulation of voluntary physical activity behavior based on selective breeding and pharmacological studies in rodents, as well as genetic studies in both rodents and humans. While these studies establish a role of dopamine and associated mechanisms in the brain in the regulation of voluntary physical activity behavior, there is clearly need for more research on the underlying biology involved in motivation for physical activity and the formation of a physical activity habit. Such knowledge at the basic science level may ultimately be translated into better strategies to enhance physical activity levels within the society.

1 March 2011 in Obesity
Verified
Journal Article
Closed access
PDF file
Christos S. KatsanosChristos S. Katsanos
Christos S. Katsanos
LMLawrence J. Mandarino
Lawrence J. Mandarino

1 August 2009 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
Christos S. KatsanosChristos S. Katsanos
Christos S. Katsanos
AAAsle Aarsland
Asle Aarsland
MCMelanie G. Cree
Melanie G. Cree
RWRobert R. Wolfe
Robert R. Wolfe
Context: Elevated plasma free fatty acid (FFA) concentrations are observed under various clinical circumstances and are associated with impaired glucose disposal in skeletal muscle. Objective: The aim of the study was to determine the effects of elevated plasma FFA concentrations on the response of protein synthesis and balance in muscle after essential amino acids (EAAs) ingestion. Design: Leg protein kinetics were determined in young healthy individuals before and after the ingestion of EAAs at 10 h after the initiation of either lipid (Liposyn/heparin+EAA) or saline (saline+EAA) infusions. Results: Plasma insulin responses where higher (P <0.05) in the Liposyn/heparin+EAA group than the saline+EAA group both before (14 ± 4 vs. 6 ± 1 μIU · ml−1) and after (1038 ± 257 vs. 280 ± 87 μIU · ml−1 · 210 min−1) the EAA ingestion. After the EAA ingestion, the rates of both leg phenylalanine disappearance (Rd; nmol · min−1 · kg lean leg mass−1) and muscle proteins fractional synthesis (FSR; % · h−1) increased (P 0.05). Although the leg phenylalanine rate of appearance (Ra; nmol · min−1 · kg lean leg mass−1) was lower (381 ± 47 vs. 518 ± 40) and the balance was greater (−109 ± 20 vs. −172 ± 17) in the Liposyn/heparin+EAA group compared to the saline+EAA group before the EAA ingestion (P 0.05). Conclusions: Elevated plasma FFA concentrations do not interfere with the response of muscle protein synthesis and balance to a bolus ingestion of EAAs.

1 December 2023 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
NSNathan Serrano
Nathan Serrano
JHJon-Philippe K. Hyatt
Jon-Philippe K. Hyatt
JHJoseph A. Houmard
Joseph A. Houmard
MMMarta Murgia
Marta Murgia
Christos S. KatsanosChristos S. Katsanos
Christos S. Katsanos
The proportion of the different types of fibers in a given skeletal muscle contributes to its overall metabolic and functional characteristics. Greater proportion of type I muscle fibers is associated with favorable oxidative metabolism and function of the muscle. Humans with obesity have a lower proportion of type I muscle fibers. We discuss how lower proportion of type I fibers in skeletal muscle of humans with obesity may explain metabolic and functional abnormalities reported in these individuals. These include lower muscle glucose disposal rate, mitochondrial content, protein synthesis, and quality/contractile function, as well as increased risk for heart disease, lower levels of physical activity, and propensity for weight gain/resistance to weight loss. We delineate future research directions and the need to examine hybrid muscle fiber populations, which are indicative of a transitory state of fiber phenotype within skeletal muscle. We also describe methodologies for precisely characterizing muscle fibers and gene expression at the single muscle fiber level to enhance our understanding of the regulation of muscle fiber phenotype in obesity. By contextualizing research in the field of muscle fiber type in obesity, we lay a foundation for future advancements and pave the way for translation of this knowledge to address impaired metabolism and function in obesity.

12 June 2018 in Obesity
Verified
Journal Article
Open access
PDF file
LTLee Tran
Lee Tran
KKKaton A. Kras
Katon A. Kras
NHNyssa Hoffman
Nyssa Hoffman
JRJayachandran Ravichandran
Jayachandran Ravichandran
JDJared M. Dickinson
Jared M. Dickinson
Christos S. KatsanosChristos S. Katsanos
Christos S. Katsanos
Objective: Obesity alters protein metabolism in skeletal muscle, but consistent evidence is lacking. This study compared muscle protein synthesis in adults with obesity and in lean controls in the fasted state and during an amino acid infusion.Methods: Ten subjects with obesity (age: 36 ± 3 years; BMI: 34 ± 1 kg/m2) and ten controls (age: 35 ± 3 years; BMI: 23 ± 1 kg/m2) received an infusion of L‐[2,3,3,4,5,5,5,6,6,6‐2H10]leucine (0.15 μmol/kg fat‐free mass/min) to measure muscle protein synthesis after an overnight fast and during amino acid infusion.Results: Despite greater muscle mammalian target of rapamycin phosphorylation (P ≤ 0.05), fasted‐state mixed‐muscle and mitochondrial protein synthesis were lower in subjects with obesity (P ≤ 0.05). However, the change in mixed‐muscle protein synthesis during the amino acid infusion was 2.7‐fold greater in subjects with obesity (P ≤ 0.05), accompanied by a greater change in S6 kinase‐1 phosphorylation (P ≤ 0.05). The change in mitochondrial protein synthesis did not differ between groups (P > 0.05).Conclusions: Adults with obesity have reduced muscle protein synthesis in the fasted state, but this response is compensated for by a greater change in overall muscle protein synthesis during amino acid infusion.